Skip to content
An Initiative of AVAC
Search
Back to Country Data

Country Overview:
Ethiopia

Global PrEP Tracker
Last Updated: 19 June 2025

Drug Registration Status

Approved
Pending
Not
Approved
Lenacapavir (LEN) for PrEP — Gilead
Data Not Available
Cabotegravir (CAB) for PrEP — ViiV
Not Approved
Dapivirine Vaginal Ring (DVR) — Pop Council
Under Review
Oral PrEP TDF/FTC — Gilead (Truvada)
Approved
Oral PrEP TDF/xTC* - generic
Approved
Oral PrEP F/TAF — Gilead
Data Not Available
* TDF/xTC refers to tenofovir disoproxil fumarate (TDF) and either emtricitabine (FTC) or lamivudine (3TC)

Research, Demonstration and Implementation

Oral PrEP

1 Completed Projects

Dapivirine Vaginal Ring

N/A Planned/Ongoing Projects

Injectable PrEP

N/A Planned/Ongoing Projects

Policy Frameworks

Ethiopia National PrEP Guidelines, 2019

Ethiopia HIV/AIDS National Strategic Plan, 2021-25

National Guidelines for Prevention of Mother-to-Child Transmission of HIV, Syphilis, & Hepatitis B Virus, 2021

Est. Cumulative
Initiations:

Total PrEP: 66,951

Oral PrEP: 66,951

Dapivirine Vaginal Ring: N/A

Injectable PrEP: N/A

Featured Resources

Document

Ethiopia Strategic Direction Summary, 2023

PEPFAR-Ethiopia (PEPFAR-E) has progressed well towards reaching 95-95-95 targets despite facing a COVID-19 epidemic, armed conflict, the worst drought in 40 years, multiple infectious disease outbreaks, widespread food insecurity, and other humanitarian crises across the country. Country operational plan (COP) 23 provides an opportunity to anchor PEPFAR-E programming in the PEPFAR 5X3 strategy by collaborating…
View All Resources